Any Shades Of Pink Breast Cancer Foundation

12/25/2025

12/24/2025

Greetings From ASOP to Each and Everyone of You!

09/06/2025

Ovarian Awareness

■ Ovarian Cancer Awareness
Know the Signs. Save Lives.

What Is Ovarian Cancer?
Ovarian cancer begins in the ovaries, the female reproductive organs that produce eggs. It’s sometimes
called a “silent killer” because symptoms can be vague and often go unnoticed until later stages. Awareness
is the best defense.
Common Symptoms
• Bloating or swelling in the abdomen
• Pelvic or stomach pain
• Feeling full quickly or trouble eating
• Frequent or urgent need to urinate
• Changes in bowel habits (constipation/diarrhea)
• Unexplained fatigue or back pain
• ■ If these symptoms last more than 2 weeks, talk to your doctor.
Who’s at Risk?
• Women over age 50 (though it can happen at any age)
• Family history of ovarian, breast, or colorectal cancer
• Carrying BRCA1 or BRCA2 gene mutations
• Never having been pregnant, or late pregnancy after age 35
• Endometriosis or hormone replacement therapy
Why Early Detection Matters
When ovarian cancer is found early, 94% of women live 5+ years after diagnosis. Sadly, most cases are
diagnosed late because symptoms are mistaken for other issues. Awareness can change that.
What You Can Do
✔ Know your family history and share it with your doctor
✔ Ask about genetic testing if ovarian/breast cancer runs in your family
✔ Pay attention to your body — don’t ignore ongoing symptoms
✔ Schedule regular checkups
Treatment & Hope
Treatment may include surgery, chemotherapy, targeted therapy, or clinical trials. Many women live long,
fulfilling lives after treatment — especially when detected early.
Support & Resources
• American Cancer Society (ACS): 1-800-227-2345 | cancer.org
• Ovarian Cancer Research Alliance (OCRA): ocrahope.org
• Foundation for Women’s Cancer: foundationforwomenscancer.org
• Local Hospitals & Health Clinics: Call for screenings and support services
■ Together, We Can Save Lives
Share this brochure. Talk with your family, friends, and community. Awareness is power. Early action is hope.

To bring together all communities of advocates, patients, caregivers, partners, and the healthcare team to eradicate or lessen the impact of gynecologic cancer.

09/05/2025

It’s September Ovarian Cancer Month!

According to Generative AI Results…Stanford Health Care.Org

GenAI-based search is in Phase 1 trials. Quality and availability of the info may vary.

Ovarian cancer is one of the deadliest cancers affecting women, with a high mortality rate partly due to a lack of understanding of its origins, making prevention, early detection, and treatment challenging. [1, 2] A significant proportion of ovarian cancers originate in the fallopian tube, but studying this within the body is difficult. [1] High-grade serous ovarian tumors are particularly deadly because they often present few symptoms in their early stages. [3] Most ovarian cancers are diagnosed at advanced stages because there are no reliable early detection or screening methods. [2] Standard treatment involves surgery and chemotherapy, but recurrence is common, often requiring additional therapies without a realistic chance of cure. [2] There is an urgent need for new treatments to improve patient outcomes. [2]

One area of research focuses on how ovarian cancers evade the immune system. [3] A common type of ovarian cancer evades detection by convincing nearby immune cells to treat it as a developing fetus. [3, 4] It does this by transferring a molecule called CD9 from its cell surface to the surface of immune cells (natural killer cells) via trogocytosis. [3] CD9 is usually only found on natural killer cells during early pregnancy, signaling to the cells to stand down. [3] This transfer of CD9 reduces the natural killer cells' ability to kill cancer cells, creating a tolerant environment for the cancer's growth. [3] Blocking CD9's effect on natural killer cells could lead to new treatments, and CD9 could be a target for optimizing natural killer-based immunotherapy or predicting who might respond best to immunotherapy. [3] Researchers are also exploring the use of chimeric antigen receptor (CAR)-T cell therapy to treat advanced ovarian cancer. [2] This immunotherapy engineers a patient's T cells to target cancer cells. [2] While CAR-T therapies have been successful in blood cancers, applying them to solid tumors like ovarian cancer remains challenging. [2] Another area of research involves blocking a "don't eat me" signal used by cancer cells to evade macrophages (immune cells that digest tumors). [2] This signal is mediated by a protein called CD24, and blocking the interaction between CD24 and a molecule on macrophages called Siglec-10 reactivates macrophages, enabling them to eliminate cancer cells. [2] A therapeutic anti-CD24 antibody is currently being tested in a clinical trial. [2] Data science is also being used to identify therapies that work best for specific patients, advancing precision oncology. [4]

Please share with every woman you know!

08/25/2025

🏀💗 Breast Cancer vs. Ovarian Cancer 💙🏀
Join us for the Any Shades of Pink Basketball Benefit on Aug 31, 2025 – 4 PM at the South Holland Community Center! 🎟️ $10 admission. Come support the fight against cancer!

If you cannot attend you can still donate. Any amount would be appreciated.

Thank you!

05/17/2025

Celebrating my 9th year on Facebook. Thank you for your continuing support. I could never have made it without you. 🙏🤗🎉

02/14/2025

Happy Valentines Day My Loves!

01/01/2025

Any Shades of Pink Breast Cancer Foundation ~ would like to wish you & yours a
Happy New Year's! ,